Gennao Bio

0 followers


Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Industries

Employees

11-50

Links

Org chart

Chris Duke
Interim CEO

Chris Duke

Collapse
Dale L. Ludwig
Chief Scientific Officer
Anuj Goswami
General Counsel
Bruce T.
Board Member, Founder, and Chief Scientific Advisor
Joe Rayne
Vice President, Corporate Development
John Heyburn
Senior Vice President, Program Management
Daniel Bruno, CPA
Senior Vice President, Finance And Corporate Controller